LBS01| Volume 103, P92, September 2017

How treating women with VVA saves costs

      Women with VVA often suffer from associated comorbidities, leading to increased utilization of healthcare resources. To determine if treating VVA leads to savings in costs, we undertook a retrospective analysis of the US claims-based MarketScan® Research Database.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect